Choosing ImmunotherapyVideo Categories: 2018 AONN Midyear, Immunotherapy, and Video Library
Dr Morganna Freeman outlines some of the criteria used in deciding which patients will most benefit from immunotherapy.
Drs. David Rimm and Roy Herbst identify the top challenges in the area of biomarker testing as well as solutions to these challenges, including availability of sufficient tissue for a large number of biomarker assays, the time some biomarker tests require for completion, the need for a tight association of [ Read More ]
Dr. Steve O’Day works with melanoma and has seen great breakthroughs in targeted therapies and their impact on the disease.